Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases

Hammes, Jochen; Bischof, Gérard N.; Drzezga, Alexander

doi:10.1007/s40336-017-0242-y

Journal Article

FZJ-2018-01729

Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases

Hammes, J. (Corresponding author) ; Bischof, G. N.FZJ* ; Drzezga, A.

2017
Springer Milan Berlin

Clinical and translational imaging 5(5), 465 - 471 (2017) [10.1007/s40336-017-0242-y]

This record in other databases:

Please use a persistent id in citations: doi:10.1007/s40336-017-0242-y

Abstract: PurposeCurrent disease models suggest that many neurodegenerative disorders are associated with pathological protein aggregations that start to develop in the brain long before the onset of clinical symptoms. Therefore, biomarkers allowing early and reliable characterization of neurodegenerative disease are required. Here we illustrate the potential value of neuroimaging procedures by means of selected examples.MethodsMultimodal imaging data of exemplary patients who underwent FDG, Amyloid and AV-1451-PET, FP-CIT-SPECT and MRI imaging in the routine clinical workup in our department is presented and the currently available literature on the topic of imaging in neurodegenerative diseases was reviewed.ResultsThe complementary value of the applied imaging methods is demonstrated in pairs of representative cases. Depending on the clinical question, individual methods or a meaningful multimodal combination is required to achieve optimal diagnostic benefit.

Classification: